Accenture stock analysis: 15 times earnings, an 8.8% free cash flow yield and $11.5B returned to shareholders, but growth guided at 3% to 6%.
@2026 – All Right Reserved.
Category:
Featured
-
-
FeaturedFood & BeverageUS Stocks
Keurig Dr Pepper Earns a Buy Signal After the JDE Peet’s Deal – but Its 75.6% Sales Growth Is Mostly Acquired
Keurig Dr Pepper stock analysis: a Buy signal on a 68/100 score, but 75.6% sales growth is mostly the JDE Peet’s deal and debt is elevated.
-
BiotechnologyFeaturedUS Stocks
Incyte Grows Revenue 37.7% at a 15.46 P/E – Can It Outrun the 2028 Jakafi Patent Cliff?
Incyte stock analysis: INCY grows revenue 37.7% at a 15.46 P/E with a 98/100 Quality score. Why the model rates it a Buy despite the 2028 Jakafi cliff.
-
FeaturedPharmaceuticalsUS Stocks
United Therapeutics Rallies on Its Tyvaso IPF Filing – a 95/100 Quality Score at 19.4 Times Earnings
United Therapeutics stock analysis: UTHR rallies on its Tyvaso IPF filing with a 95/100 Quality score and a 19.40 P/E. Why the model rates it a Buy.
-
FeaturedSoftwareUS Stocks
PicPay Parent PicS N.V. Sits at Its Two-Year Low Despite 67% Revenue Growth
PicS N.V. stock analysis: PicPay’s parent grew revenue 67% yet trades at a two-year low. Quality, growth and valuation scores explained.
-
FeaturedMedia & EntertainmentUS Stocks
Fox Corporation: Modest Multiples and a Strong Balance Sheet Put It Right at the Buy Line
Fox Corporation stock analysis: a 25.2% operating margin, strong liquidity and 7.7x EV/EBITDA put FOXA right at the model’s Buy line.
-
Analyst Upgrades & DowngradesFeatured
Analyst Upgrades Point to a Broader Market Rotation Into Value
Analyst upgrades across financials, industrials and other value sectors signal broader market rotation as institutions reassess earnings breadth.